IMNM · Immunome Inc. · Documents
$17.96
+0.04 (+0.22%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.04B
Shares
113.58M
Volume · Oct 21
932.77K
Avg daily vol (3M)
1.23M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFA14A | — | 2022-04-29 | — | |
| DEF 14A | — | 2022-04-29 | 2022-06-15 | |
| 8-K | — | 2022-03-28 | — | |
| 10-K | — | 2022-03-28 | 2021-12-31 | |
| 8-K | — | 2022-03-11 | — | |
| 8-K | — | 2022-02-08 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2021-11-29 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-10-18 | — | |
| S-3 | — | 2021-10-01 | — | |
| 8-K | — | 2021-09-21 | — | |
| 8-K | — | 2021-09-08 | 2021-09-07 | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-08-05 | 2021-08-01 | |
| 8-K | — | 2021-07-20 | — | |
| 8-K | — | 2021-06-17 | 2021-06-16 | |
| 8-K | — | 2021-06-01 | 2021-05-27 | |
| S-1/A | — | 2021-05-26 | — | |
| S-1/A | — | 2021-05-21 | — | |
| 8-K | — | 2021-05-20 | 2021-05-19 | |
| 10-Q | — | 2021-05-12 | 2021-03-31 | |
| 8-K | — | 2021-05-12 | — | |
| S-1 | — | 2021-05-11 | — | |
| 8-K | — | 2021-04-26 | — | |
| 8-K | — | 2021-04-26 | — | |
| 8-K | — | 2021-04-20 | 2021-04-19 | |
| DEFA14A | — | 2021-04-16 | — | |
| DEF 14A | — | 2021-04-16 | 2021-05-27 | |
| 8-K | — | 2021-03-29 | — | |
| 8-K | — | 2021-03-25 | — | |
| 10-K | — | 2021-03-25 | 2020-12-31 | |
| 8-K | — | 2021-03-16 | 2021-03-15 | |
| 8-K | — | 2020-12-04 | 2020-11-30 | |
| 8-K | — | 2020-11-17 | — | |
| 10-Q | — | 2020-11-16 | 2020-09-30 | |
| 8-K | — | 2020-10-26 | — | |
| 8-K | — | 2020-10-06 | — | |
| S-1/A | — | 2020-09-24 | — | |
| S-1 | — | 2020-09-09 | — |
Showing 101–140 of 140 filings
Key facts
CIK
1472012
CUSIP
45257U108
13F (30d)
11 filings
11 filers
Visit website
Investor relations